Patents by Inventor Yissum Research Development Company of the Hebrew University of Jerusalem LTD

Yissum Research Development Company of the Hebrew University of Jerusalem LTD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130315598
    Abstract: A system and method are presented for use in dense wavelength division multiplexing. According to this technique, K spatially separated broadband optical beams are produced comprising respective K arrays of spectral components arranged with certain common periodicity, P, where the spectral components present data channels and are arranged in interleaved fashion in the K arrays, with spectral components of one array being shifted with respect to the next array a value substantially equal to said periodicity divided by number of separated broadband beams, or P(K?1)/K. Spectral shaping is applied to the K arrays to convert modulated-shape of the spectral components in the K arrays to K groups of desired spectral shape of data channels. This enables to combine the K groups of the spectral channels into a combined beam comprising all the spectral channels being arranged with substantially no gap between the channels.
    Type: Application
    Filed: April 25, 2013
    Publication date: November 28, 2013
    Inventor: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
  • Publication number: 20130310441
    Abstract: AChE antisense oligonucleotides are used as antiinflammatory agents, such oligonucleotides preferably having the sequence of SEQ ID NO:1 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation of the gastrointestinal tract, are described.
    Type: Application
    Filed: May 22, 2013
    Publication date: November 21, 2013
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventor: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
  • Publication number: 20130302861
    Abstract: A method of producing at least one terpene in a yeast cell is disclosed. The method comprises exogenously expressing within the mitochondria of the yeast cell or directing localization thereto a terpene synthase.
    Type: Application
    Filed: May 14, 2013
    Publication date: November 14, 2013
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventor: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
  • Publication number: 20130225793
    Abstract: Isolated polypeptides are disclosed comprising an amino acid sequence encoding a monomer of a fibrous polypeptide attached to a heterologous polysaccharide binding domain. Composites comprising same, methods of generating same and uses thereof are all disclosed.
    Type: Application
    Filed: April 25, 2013
    Publication date: August 29, 2013
    Applicants: CollPlant Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., CollPlant Ltd.
  • Publication number: 20130218075
    Abstract: An implantable apparatus for internal treatment of body cavities and damaged vessels using electromagnetic radiation having an implantable light source is operationally connected to an implantable illuminating surface. The implantable light source and implantable illuminating surface are of materials, which are compatible with implantation in a human subject, and possessed of an expanded, deployed configuration and compact, undeployed configuration suitable for laparoscopic insertion within a body cavity for application, when deployed, to an outer, periadventitial surface of an internal vessel or surface of an organ. The apparatus also has a control unit, which control unit regulates the activation of said light source and is optionally located remotely from the implantable light source and illuminating surface.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 22, 2013
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
    Inventor: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
  • Publication number: 20130190393
    Abstract: The described subject matter relates to the use of incensole, incensole acetate, and derivatives thereof, for the treatment, prevention or amelioration of diseases or conditions, including inflammatory-associated conditions; a disease or condition where neuroprotection is required; and a disease or condition selected from depression, anxiety, obsessive compulsive behaviors, deterioration in cognitive function, and deterioration in neurobehavioral function. Pharmaceutical compositions and method of treatment, prevention or amelioration of the above-mentioned diseases or conditions are also provided.
    Type: Application
    Filed: December 4, 2012
    Publication date: July 25, 2013
    Applicants: ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD., ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD.
  • Publication number: 20130153783
    Abstract: The present invention discloses a system and method for generating a beam of fast ions. The system comprising: a target substrate having a patterned surface, a pattern comprising nanoscale pattern features oriented substantially uniformly along a common axis; and; a beam unit adapted for receiving a high power coherent electromagnetic radiation beam and providing an electromagnetic radiation beam having a main pulse and a pre-pulse and focusing it onto said patterned surface of the target substrate to cause interaction between said radiation beam and said substrate enabling creation of fast ions.
    Type: Application
    Filed: January 29, 2013
    Publication date: June 20, 2013
    Applicants: HIL Applied Medical Ltd., Yissum Research Development Company of the Hebrew University of Jersusalem Ltd.
    Inventors: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., HIL Applied Medical Ltd.
  • Publication number: 20130122041
    Abstract: The present invention relates to an attenuated strain of Ehrlichia canis and a vaccine comprising said attenuated strain for protection of mammals against ehrlichiosis. The invention further relates to methods of preventing ehrlichiosis and of attenuating the pathogenicity Ehrlichia canis.
    Type: Application
    Filed: December 31, 2012
    Publication date: May 16, 2013
    Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventor: Yissum Research Development Company of the Hebrew University of Jerusalem LTD